Loading patent…
AssigneeAnthrogenesis Corporation
InventorsStewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
Estimating the term…
Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
An isolated placental derived adherent cell, wherein said cell is adherent to tissue culture plastic, and wherein said cell is CD10+, CD34−, CD105+ and CD200+ as determined by flow cytometry, and wherein said cell (1) promotes the proliferation of endothelial cells;
The isolated population of cells of claim 7, wherein at least 50% of the cells in said population are the cells of claim 1.
Dependencies are inferred from the claim text.